Robin Aldrich

Robin Aldrich is a QC Analyst III at Pfizer Inc., bringing 15 years of industry experience focused on the development of biologics, particularly monoclonal antibodies and antibody-drug conjugates. Robin's diverse background includes analytical quality control, GMP manufacturing, and molecule development, with a proven track record in data verification and method optimization. Previously, Robin held roles at notable companies such as Seattle Genetics, Ambrx, and ImmunityBio, contributing to various analytical and quality control initiatives. Robin earned a Bachelor of Science degree with a major in Cellular Biology from Western Washington University.